In Segment A, individuals will get different doses and schedules of oral ABBV-744 pill to establish Secure dosing regimen. Supplemental participants will probably be enrolled for the recognized monotherapy dosign program. In Phase B, individuals will get oral ruxolitinib and ABBV-744 will be supplied as "incorporate-on" therapy. In Segment C, https://daltoncqcpc.idblogz.com/32473759/a-simple-key-for-abbv-744-for-targeted-cancer-therapy-treatment-unveiled